v3.26.1
Statements of Changes in Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Issued capital [member]
Capital reserve [member]
Accumulated other comprehensive income [member]
Reserve with respect to transactions with non-controlling parties [member]
Retained earnings [member]
Non-controlling interests [member]
Total
Balance at Dec. 31, 2022 $ 43,452 $ 30,863 $ (1,634) $ (67,395) $ (2,397) $ 2,889
Balance, shares at Dec. 31, 2022 12,378,129            
IfrsStatementLineItems [Line Items]              
Net loss for the year (16,061) (1,996) (18,057) [1]
Adjustments arising from translating financial statements of foreign operations 303 303
Total comprehensive income (loss) for the year 304 (16,061) (1,996) (17,753) [1]
Transactions with non-controlling parties 927 (405) 522
Exercise of RSU’s (note 18(E))
Exercise of RSUs, shares 185,800            
Exercise of warrants (note 18(D)) $ 102 102
Exercise of warrants, shares 36,800            
Share based compensation $ 4,802 4,802
Share based compensation, shares            
Remeasurement loss from defined benefit plans 1 1 [1]
Issuances of shares (note 18) $ 7,129 7,129
Issuances of shares, shares 2,759,047            
Balance at Dec. 31, 2023 $ 55,485 30,863 (1,330) 927 (83,456) (4,798) (2,309)
Balance, shares at Dec. 31, 2023 15,359,799            
IfrsStatementLineItems [Line Items]              
Net loss for the year   (16,996) (2,267) (19,263) [1]
Adjustments arising from translating financial statements of foreign operations 775 775
Total comprehensive income (loss) for the year 781 (16,996) (2,267) (18,482) [1]
Exercise of RSU’s (note 18(E))
Exercise of RSUs, shares 764,001            
Exercise of warrants (note 18(D)) $ 576 576
Exercise of warrants, shares 1,330,300            
Share based compensation $ 1,913 1,913
Share based compensation, shares            
Remeasurement loss from defined benefit plans 6 6 [1]
Issuances of shares (note 18) $ 24,696 24,696
Issuances of shares, shares 12,136,197            
Balance at Dec. 31, 2024 $ 83,120 30,863 (549) 927 (100,452) (7,065) 6,844
Balance, shares at Dec. 31, 2024 29,590,297            
IfrsStatementLineItems [Line Items]              
Net loss for the year (37,735) (749) (38,484)
Adjustments arising from translating financial statements of foreign operations (1,323) (1,323)
Total comprehensive income (loss) for the year (1,323) (37,735) (749) (39,807)
Issuance of shares in January 2025 private placement (note 18) $ 25,946 1,368 27,314
Issuance of shares in January 2025 private placement, shares 4,748,150            
Issuance of shares in September 2025 private placement (note 18) $ 39,781 1,960 41,741
Issuance of shares in September 2025 private placement, shares 5,625,000            
Transactions with non-controlling parties $ (8,117) 6,267 (1,850)
Exercise of RSU’s (note 18(E))
Exercise of RSUs, shares 219,667            
Exercise of warrants (note 18(D)) $ 45,318 (24,044) 21,274
Exercise of warrants, shares 3,474,596            
Exercise of options (note 18(Q)) $ 548 548
Exercise of options, shares 225,332            
Shares issued for services(note 18(s)) $ 35 35
Shares issued for services, shares 5,000            
Share based compensation $ 20,322 20,322
Share based compensation, shares            
Remeasurement loss from defined benefit plans            
Balance at Dec. 31, 2025 $ 206,953 $ 10,147 $ (1,872) $ 927 $ (138,187) $ (1,547) $ 76,421
Balance, shares at Dec. 31, 2025 43,888,042            
[1] Reclassified due to discontinued operations (note 32).